Effects of amino acid substitutions in the VP2 B-C loop on antigenicity and pathogenicity of serotype Asia1 foot-and-mouth disease virus

Virology Journal

Li Yu¹  Yabin Tu¹  Guohui Zhou¹  Wan Li¹  Haiwei Wang¹  Mei Xue¹ 

[1] Division of Livestock Infectious Diseases, State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, No. 427 Maduan Street, Harbin, 150001, P. R. China

关键词: Virulence;    Replication ability;    Antigenic variation;    VP2;    Foot-and-mouth disease virus;   

Others  :  1153899
DOI  :  10.1186/1743-422X-9-191

 received in 2011-09-23, accepted in 2012-08-31,  发布年份 2012

【 摘 要 】

Background

Foot-and-mouth disease virus (FMDV) exhibits a high degree of antigenic variability. Studies of the antigenic diversity and determination of amino acid changes involved in this diversity are important to the design of broadly protective new vaccines. Although extensive studies have been carried out to explore the molecular basis of the antigenic variation of serotype O and serotype A FMDV, there are few reports on Asia1 serotype FMDV.

Methods

Two serotype Asia1 viruses, Asia1/YS/CHA/05 and Asia1/1/YZ/CHA/06, which show differential reactivity to the neutralizing monoclonal antibody (nMAb) 1B4, were subjected to sequence comparison. Then a reverse genetics system was used to generate mutant versions of Asia1/YS/CHA/05 followed by comparative analysis of the antigenicity, growth property and pathogenicity in the suckling mice.

Results

Three amino acid differences were observed when the structural protein coding sequences of Asia1/1/YZ/CHA/06 were compared to that of Asia1/YS/CHA/05. Site-directed mutagenesis and Immunofluorescence analysis showed that the amino acid substitution in the B-C loop of the VP2 protein at position 72 is responsible for the antigenic difference between the two Asia1 FMDV strains. Furthermore, alignment of the amino acid sequences of VP2 proteins from serotype Asia1 FMDV strains deposited in GenBank revealed that most of the serotype Asia1 FMDV strains contain an Asn residue at position 72 of VP2. Therefore, we constructed a mutant virus carrying an Asp-to-Asn substitution at position 72 and named it rD72N. Our analysis shows that the Asp-to-Asn substitution inhibited the ability of the rD72N virus to react with the MAb 1B4 in immunofluorescence and neutralization assays. In addition, this substitution decreased the growth rate of the virus in BHK-21 cells and decreased the virulence of the virus in suckling mice compared with the Asia1/YS/CHA/05 parental strain.

Conclusions

These results suggest that variations in domains other than the hyper variable VP1 G-H loop (amino acid 140 to 160) are relevant to the antigenic diversity of FMDV. In addition, amino acid substitutions in the VP2 influenced replicative ability and virulence of the virus. Thus, special consideration should be given to the VP2 protein in research on structure-function relationships and in the development of an FMDV vaccine.

【 授权许可】

   
2012 Xue et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Grubman MJ, Baxt B: Foot-and-Mouth Disease. Clin Microbiol Rev 2004, 17:465-493.
• [2]Belsham GJ: Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog Biophys Mol Biol 1993, 60:241-260.
• [3]Sobrino F, Palma EL, Beck E, Davila M, de la Torre JC, Negro P, Villanueva N, Ortin J, Domingo E: Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Gene 1986, 50:149-159.
• [4]Marquardt O, Rahman MM, Freiberg B: Genetic and antigenic variance of foot-and-mouth disease virus type Asia1. Arch Virol 2000, 145:149-157.
• [5]Domingo E, Escarmis C, Baranowski E, Ruiz-Jarabo CM, Carrillo E, Nunez JI, Sobrino F: Evolution of foot-and-mouth disease virus. Virus Res 2003, 91:47-63.
• [6]Borrego B, Camarero JA, Mateu MG, Domingo E: A highly divergent antigenic site of foot-and-mouth disease virus retains its immunodominance. Viral Immunol 1995, 8:11-18.
• [7]Mateu MG, Camarero JA, Giralt E, Andreu D, Domingo E: Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 1995, 206:298-306.
• [8]Pfaff E, Thiel HJ, Beck E, Strohmaier K, Schaller H: Analysis of neutralizing epitopes on foot-and-mouth disease virus. J Virol 1988, 62:2033-2040.
• [9]Feigelstock D, Mateu MG, Piccone ME, De Simone F, Brocchi E, Domingo E, Palma EL: Extensive antigenic diversification of foot-and-mouth disease virus by amino acid substitutions outside the major antigenic site. J Gen Virol 1992, 73(Pt 12):3307-3311.
• [10]Barnett PV, Ouldridge EJ, Rowlands DJ, Brown F, Parry NR: Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. J Gen Virol 1989, 70(Pt 6):1483-1491.
• [11]Saiz JC, Gonzalez MJ, Borca MV, Sobrino F, Moore DM: Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J Virol 1991, 65:2518-2524.
• [12]Mateu MG, Hernandez J, Martinez MA, Feigelstock D, Lea S, Perez JJ, Giralt E, Stuart D, Palma EL, Domingo E: Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J Virol 1994, 68:1407-1417.
• [13]Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F: The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature 1989, 337:709-716.
• [14]Bolwell C, Brown AL, Barnett PV, Campbell RO, Clarke BE, Parry NR, Ouldridge EJ, Brown F, Rowlands DJ: Host cell selection of antigenic variants of foot-and-mouth disease virus. J Gen Virol 1989, 70(Pt 1):45-57.
• [15]Valarcher JF, Knowles NJ, Zakharov V, Scherbakov A, Zhang Z, Shang YJ, Liu ZX, Liu XT, Sanyal A, Hemadri D, et al.: Multiple origins of foot-and-mouth disease virus serotype Asia 1 outbreaks, 2003-2007. Emerg Infect Dis 2009, 15:1046-1051.
• [16]Du J, Chang H, Cong G, Shao J, Lin T, Shang Y, Liu Z, Liu X, Cai X, Xie Q: Complete nucleotide sequence of a Chinese serotype Asia1 vaccine strain of foot-and-mouth disease virus. Virus Genes 2007, 35:635-642.
• [17]Valarcher JF, Knowles NJ, Ferris NP, Paton DJ, Zakharov V, Sherbakov A, Shang YJ, Liu ZX, Liu XT, Sanyal A, et al.: Recent spread of FMD virus serotype Asia 1. Vet Rec 2005, 157:30.
• [18]Guo H, Liu X, Liu Z, Yin H, Ma J, Wang Y, Shang Y, Zhang Q, Li D, Guo J, et al.: Recent Outbreaks of Foot-and-Mouth Disease Type Asia 1 in China. J Vet Med B Infect Dis Vet Public Health 2006, 53:29-33.
• [19]Ferrer-Orta C, Arias A, Perez-Luque R, Escarmis C, Domingo E, Verdaguer N: Structure of foot-and-mouth disease virus RNA-dependent RNA polymerase and its complex with a template-primer RNA. J Biol Chem 2004, 279:47212-47221.
• [20]Drake JW, Holland JJ: Mutation rates among RNA viruses. Proc Natl Acad Sci U S A 1999, 96:13910-13913.
• [21]Parry NR, Barnett PV, Ouldridge EJ, Rowlands DJ, Brown F: Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. J Gen Virol 1989, 70(Pt 6):1493-1503.
• [22]Moore DM, Vakharia VN, Morgan DO: Identification of virus neutralizing epitopes on naturally occurring variants of type A12 foot-and-mouth disease virus. Virus Res 1989, 14:281-295.
• [23]Thomas AA, Woortmeijer RJ, Puijk W, Barteling SJ: Antigenic sites on foot-and-mouth disease virus type A10. J Virol 1988, 62:2782-2789.
• [24]Freiberg B, Hohlich B, Haas B, Saalmuller A, Pfaff E, Marquardt O: Type-independent detection of foot-and-mouth disease virus by monoclonal antibodies that bind to amino-terminal residues of capsid protein VP2. J Virol Methods 2001, 92:199-205.
• [25]Barnett PV, Samuel AR, Pullen L, Ansell D, Butcher RN, Parkhouse RM: Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse. J Gen Virol 1998, 79(Pt 7):1687-1697.
• [26]Curry S, Fry E, Blakemore W, Abu-Ghazaleh R, Jackson T, King A, Lea S, Newman J, Rowlands D, Stuart D: Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Structure 1996, 4:135-145.
• [27]Fox G, Parry NR, Barnett PV, McGinn B, Rowlands DJ, Brown F: The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol 1989, 70(Pt 3):625-637.
• [28]Baxt B, Becker Y: The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Virus Genes 1990, 4:73-83.
• [29]Zhang Q, Li D, Liu X, Liu Z, Cai X, Wu G, Qi S, Yang S, Yan X, Shang Y, et al.: Experimental studies with foot-and-mouth disease virus type Asia-1, responsible for the 2005 epidemic in China. Res Vet Sci 2008, 85:368-371.
• [30]Wang H, Zhao L, Li W, Zhou G, Yu L: Identification of a conformational epitope on the VP1 G-H Loop of type Asia1 foot-and-mouth disease virus defined by a protective monoclonal antibody. Vet Microbiol 2011, 148:189-199.
• [31]Yu Y, Wang H, Zhao L, Zhang C, Jiang Z, Yu L: Fine mapping of a foot-and-mouth disease virus epitope recognized by serotype-independent monoclonal antibody 4B2. J Microbiol 2011, 49:94-101.
• [32]Fisher CL, Pei GK: Modification of a PCR-based site-directed mutagenesis method. Biotechniques 1997, 23:570-574.